GlaxoSmithKline says it’s still committed to investing in Stevenage despite announcing redundancies
- Credit: Archant
A pharmaceuticals giant is making redundancies at its Stevenage site as part of a global restructuring programme.
GlaxoSmithKline announced in December that it’s changing its research and development organisation, which will mean jobs losses in the coming months, but says it’s still committed to the future of the Gunnels Wood Road site.
A spokesman for the firm said: “While there will be some job losses we’re also making investments and building new capabilities that will create new roles.
“We will be doing all we can to minimise job losses, including supporting those displaced from current roles to apply for the new ones being created.
“We’re committed to continuing our significant research and development operations in the Stevenage area – it’s one of our two global centres and critical to the future of our medicines pipeline.”
You may also want to watch:
The restructuring programme also aims to modernise the firm’s research and development programme.
It is not currently known how many redundancies will be required.
- 1 7 haunted locations that will give you a Halloween fright
- 2 Memories of a famous FA Cup run for Stevenage after first round draw made
- 3 Man taken to hospital after crash involving mobility scooter and motorhome
- 4 Man dies after Stevenage e-scooter crash
- 5 Road closures following crash in Letchworth
- 6 Case for the defence needed quickly after bad defeat for Stevenage
- 7 5 of the best pumpkin picking locations in Hertfordshire
- 8 Letchworth paedophile jailed for sexual activity with a child
- 9 As Michael Keaton's Batman returns, Knebworth House features in first teaser for The Flash movie
- 10 Opening of long-awaited Stevenage supermarket